LPM3480226
- Generic Name
- LPM3480226
A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid Tumors
- First Posted Date
- 2019-02-18
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Luye Pharma Group Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03844438
- Locations
- 🇨🇳
Beijing Cancer Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath